Overview

This trial is active, not recruiting.

Condition colorectal cancer
Treatment comparing 2 drugs on their effect on the bowel preparation for colonoscopy
Phase phase 4
Sponsor Rush University Medical Center
Start date February 2012
End date November 2012
Trial size 150 participants
Trial identifier NCT01695863, 11042705

Summary

This study will be comparing patient satisfaction, efficacy comparing miralax with gatorade versus Movi Prep for outpatient colonoscopy.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification safety/efficacy study
Intervention model parallel assignment
Masking single blind (investigator)
Primary purpose screening
Arm
(Experimental)
miralax with dulcolax and gatorade efficacy evaluated by colonoscopy and patient satisfaction evaluated by patient questionnaire
comparing 2 drugs on their effect on the bowel preparation for colonoscopy
the effects of the drug on the colon preparation for colonoscopy
(Experimental)
Efficacy of split dose moviprep on cleansing colon for colonoscopy and patient satisfaction with the regimen
comparing 2 drugs on their effect on the bowel preparation for colonoscopy
the effects of the drug on the colon preparation for colonoscopy

Primary Outcomes

Measure
bowel prep efficacy
time frame: 8 months

Secondary Outcomes

Measure
assess change in renal function pre and post bowel prep
time frame: 8 months

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: - outpatient colonoscopy for screening for other Gi related problems Exclusion Criteria: - Severe CHF, - CKD, - less than age 18 or more than 80 years

Additional Information

Official title Phase 4 of Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep
Principal investigator Maqsood A Khan, MD
Description Study is the purpose of evaluating patient satisfaction and at the same time efficacy of the bowel regimen in cleansing the colon
Trial information was received from ClinicalTrials.gov and was last updated in March 2013.
Information provided to ClinicalTrials.gov by Rush University Medical Center.